E-submission
Search
- Page Path
- HOME > Search
Original Article
- Expression of PD-1/PD-L1 pathway molecules in human cardiac allograft according to acute cellular rejection status: insights from a Korean Heart Transplant Cohort
- Jeemin Yim, Yoon Kyung Jeon, Doo Hyun Chung, Jaemoon Koh
- Received September 30, 2025 Accepted December 31, 2025 Published online March 27, 2026
- DOI: https://doi.org/10.4132/jptm.2026.01.02 [Epub ahead of print]
- 530 View
- 29 Download
-
Abstract
PDF - Background
Acute cellular rejection (ACR) following heart transplantation (TPL) compromises graft function and survival. The programmed cell death-1 (PD-1)/PD-1 ligand-1 (PD-L1) pathway represents an immune checkpoint that maintains peripheral immune tolerance, but its expression and significance in human cardiac allografts with ACR remain unclear. Thus, we investigated PD-1/ PD-L1 expression in endomyocardial biopsies from heart TPL recipients to clarify the role of this pathway in the ACR of human cardiac allografts and explore the potential of therapeutic modulation of PD-1/PD-L1 in this setting. Methods: Endomyocardial biopsies of 78 patients with heart TPL were subjected to immunohistochemistry for PD-L1, PD-1, CD4, and CD8. PD-L1 expression and quantities of PD-1+, CD4+, and CD8+ infiltrating lymphocytes were evaluated according to clinicopathological features, ACR presence, and clinical outcomes. Results: Allografts with high-grade ACR (International Society for Heart and Lung Transplantation grades 2R and 3R) demonstrated markedly higher PD-L1 expression than did those without ACR (62.5% vs. 16.1%, p < .001). PD-L1 expression was positively associated with CD4+ lymphocyte infiltration (p = .025), whereas CD8 and PD-1+ lymphocyte counts were higher in PD-L1-positive allografts without reaching statistical significance (p = .059 and p = .390, respectively). Serial biopsies revealed that PD-L1 expression was upregulated in patients with high-grade ACR compared with that in previous non-ACR tissues, and follow-up biopsies were performed after ACR resolution. Conclusions: The PD-1/PD-L1 pathway is involved in ACR regulation in human cardiac allografts. Increased PD-L1 expression during ACR may represent a counteractive mechanism to limit alloimmune-mediated tissue injury, supporting PD-1/PD-L1 as a potential therapeutic target in heart TPL recipients.
Brief Case Report
- Benign Indolent CD56-Positive NK-Cell Lymphoproliferative Lesion Involving Gastrointestinal Tract in an Adolescent
- Jaemoon Koh, Heounjeong Go, Won Ae Lee, Yoon Kyung Jeon
- Korean J Pathol. 2014;48(1):73-76. Published online February 25, 2014
- DOI: https://doi.org/10.4132/KoreanJPathol.2014.48.1.73
- 9,661 View
- 62 Download
- 20 Crossref
-
PDF
-
Citations
Citations to this article as recorded by
- Indolent T- and Natural Killer-Cell Lymphomas and Lymphoproliferative Diseases—Entities in Evolution
Chi Sing Ng
Lymphatics.2025; 3(4): 41. CrossRef - Indolent T-Cell/Natural Killer-Cell Lymphomas/Lymphoproliferative Disorders of the Gastrointestinal Tract—What Have We Learned in the Last Decade?
Xin-Gen Wang, Wei-Hua Yin, Huan-You Wang
Laboratory Investigation.2024; 104(4): 102028. CrossRef - A case of excisionally remitted indolent NK‐cell enteropathy in the oral cavity and a mini‐review
Xiangyun Li, Zhu Li, Xiaoge Zhou, Yuanyuan Zheng, Yanlin Zhang, Jianlan Xie
Journal of Cutaneous Pathology.2024; 51(7): 518. CrossRef - Clinicopathological and molecular features of indolent natural killer‐cell lymphoproliferative disorder of the gastrointestinal tract
Hongmei Yi, Anqi Li, Binshen Ouyang, Qian Da, Lei Dong, Yingting Liu, Haimin Xu, Xiaoyun Zhang, Wei Zhang, Xiaofen Jin, Yijin Gu, Yan Wang, Zebing Liu, Chaofu Wang
Histopathology.2023; 82(4): 567. CrossRef - Indolent T- and NK-Cell Lymphoproliferative Disorders of the Gastrointestinal Tract: Current Understanding and Outstanding Questions
Craig R. Soderquist, Govind Bhagat
Hemato.2022; 3(1): 219. CrossRef - Lymphomatoid gastropathy/NK-cell enteropathy involving the stomach and intestine
Makoto Nakajima, Masayuki Shimoda, Kengo Takeuchi, Akito Dobashi, Takanori Kanai, Yae Kanai, Yasushi Iwao
Journal of Clinical and Experimental Hematopathology.2022; 62(2): 114. CrossRef - Cellular Origins and Pathogenesis of Gastrointestinal NK- and T-Cell Lymphoproliferative Disorders
Susan Swee-Shan Hue, Siok-Bian Ng, Shi Wang, Soo-Yong Tan
Cancers.2022; 14(10): 2483. CrossRef - Lymph node involvement by enteropathy-like indolent NK-cell proliferation
Jean-Louis Dargent, Nicolas Tinton, Mounir Trimech, Laurence de Leval
Virchows Archiv.2021; 478(6): 1197. CrossRef - Diagnostic approach to T- and NK-cell lymphoproliferative disorders in the gastrointestinal tract
Swee-Shan Hue Susan, Siok-Bian Ng, Shi Wang, Soo-Yong Tan
Seminars in Diagnostic Pathology.2021; 38(4): 21. CrossRef - Natural Killer-cell Enteropathy of the Stomach in an Elderly Woman: A Case Report
Ye young Koo, Jin Lee, Bomi Kim, Su Jin Jeong, Eun Hye Oh, Yong Eun Park, Jongha Park, Tae Oh Kim
The Korean Journal of Gastroenterology.2021; 78(6): 349. CrossRef - Gastrointestinal T- and NK-cell lymphomas and indolent lymphoproliferative disorders
Craig R. Soderquist, Govind Bhagat
Seminars in Diagnostic Pathology.2020; 37(1): 11. CrossRef - T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: review and update
Chris van Vliet, Dominic V. Spagnolo
Pathology.2020; 52(1): 128. CrossRef - An Enteropathy-like Indolent NK-Cell Proliferation Presenting in the Female Genital Tract
Rahul Krishnan, Kari Ring, Eli Williams, Craig Portell, Elaine S. Jaffe, Alejandro A. Gru
American Journal of Surgical Pathology.2020; 44(4): 561. CrossRef - NK-cell enteropathy, a potential diagnostic pitfall of intestinal lymphoproliferative disease
Runjin Wang, Sanjay Kariappa, Christopher W. Toon, Winny Varikatt
Pathology.2019; 51(3): 338. CrossRef - Indolent T cell lymphoproliferative disorder with villous atrophy in small intestine diagnosed by single-balloon enteroscopy
Takashi Nagaishi, Daiki Yamada, Kohei Suzuki, Ryosuke Fukuyo, Eiko Saito, Masayoshi Fukuda, Taro Watabe, Naoya Tsugawa, Kengo Takeuchi, Kouhei Yamamoto, Ayako Arai, Kazuo Ohtsuka, Mamoru Watanabe
Clinical Journal of Gastroenterology.2019; 12(5): 434. CrossRef - NK-Cell Enteropathy and Similar Indolent Lymphoproliferative Disorders
Daniel Xia, Elizabeth A Morgan, David Berger, Geraldine S Pinkus, Judith A Ferry, Lawrence R Zukerberg
American Journal of Clinical Pathology.2018;[Epub] CrossRef - Clinicopathological categorization of Epstein–Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications
Jin Ho Paik, Ji-Young Choe, Hyojin Kim, Jeong-Ok Lee, Hyoung Jin Kang, Hee Young Shin, Dong Soon Lee, Dae Seog Heo, Chul-Woo Kim, Kwang-Hyun Cho, Tae Min Kim, Yoon Kyung Jeon
Leukemia & Lymphoma.2017; 58(1): 53. CrossRef - Indolent T‐ and NK‐cell lymphoproliferative disorders of the gastrointestinal tract: a review and update
Rahul Matnani, Karthik A. Ganapathi, Suzanne K. Lewis, Peter H. Green, Bachir Alobeid, Govind Bhagat
Hematological Oncology.2017; 35(1): 3. CrossRef - Indolent NK cell proliferative lesion mimicking NK/T cell lymphoma in the gallbladder
Su Hyun Hwang, Joon Seong Park, Seong Hyun Jeong, Hyunee Yim, Jae Ho Han
Human Pathology: Case Reports.2016; 5: 39. CrossRef - Recent advances in intestinal lymphomas
Periklis G Foukas, Laurence de Leval
Histopathology.2015; 66(1): 112. CrossRef
- Indolent T- and Natural Killer-Cell Lymphomas and Lymphoproliferative Diseases—Entities in Evolution
First
Prev
